Description:

Fluorodeoxyglucose is composed of mannose triflate-type glucose molecules, labelled with the radioisotope fluorine-18. Its applications range from oncology, including distinguishing metastases from original tumors, to cardiology, neurology and infectious diseases.

Technical characteristics:

Chemical form: glucose molecules labelled with fluorine-18 in water solution. Solution: limpid, sterile, apyrogenic, injectable Radiochemical purity: > 98 % Radionuclidic purity: > 99.9 % pH: between 6 and 7 Half-life: 109 minutes Radioactive concentration: 740 to 1850 MBq/ml (20 to 50 mCi/ml) Calibration: to be used at 1 PM on the same day of production Distribution: ready for transportation as of 12 h on production days Storage: room temperature

Applications:

This radiopharmaceutical is a great precision tool for the diagnosis of pathologies in which there is glucose metabolism. It is used in exams like SPECT (Single photon emission computed tomography) or PET (Positron Emission Tomography), the latter with an image resolution capable of detecting 2 mm tumors. Due to its very short half-life, of only 109 minutes, it can only be supplied by IEN to hospitals and clinics in the capital of Rio de Janeiro and adjacent cities.